Cancer Tissue Diagnostics Market in North America Benefits from Expanding Biomarker Testing Applications
North America holds a substantial share of the Cancer Tissue Diagnostics Market, driven by its robust healthcare infrastructure, extensive cancer research activities, and growing emphasis on precision oncology. The region benefits from widespread adoption of advanced diagnostic technologies, including molecular pathology, immunohistochemistry, digital pathology, and genomic testing solutions....
0 Comments 0 Shares 104 Views